Evidence map›Paper›PMID 37263266›Full record

ReviewNeuron2023

New perspectives in diabetic neuropathy.

Stephanie A Eid, Amy E Rumora, Bogdan Beirowski, David L Bennett, Junguk Hur, Masha G Savelieff, Eva L Feldman

Open access · greenAbstract readReview
In one paragraph

Review in Neuron, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 9 pooled it
34.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 9 syntheses or guidelines pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Review
  11. Review
  12. NONcNZO10/LtJ and TALLY-HO/JngJ Mice as Novel Models of Diabetic Peripheral Neuropathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Exploration of a Multimodal Machine Learning Model Integrating Ultrasound and Clinical Indicators for the Diagnosis of Diabetic Peripheral Neuropathy.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Review

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Stephanie A EidDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI 48109, USA.
Amy E RumoraDepartment of Neurology, Columbia University, New York, NY 10032, USA.
Bogdan BeirowskiDepartment of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Neuroscience Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
David L BennettNuffield Department of Clinical Neuroscience, University of Oxford, Oxford OX3 9DU, UK.
Junguk HurDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Masha G SavelieffDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Eva L FeldmanDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: efeldman@umich.edu.
University of Michigan · USUniversity of North Dakota · USColumbia University · USThe Ohio State University Wexner Medical Center · USUniversity of Oxford · GB

Funding

Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Remi J Creusot · 2003 to 2026
$36.7M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILLIAM H HERMAN · 2013 to 2026
$24.3M
Schwann Cell Senescence and the Secretome Provide a Unifying Mechanism for the Onset and Progression of Diabetic NeuropathyR01DK130913 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eva Lucille Feldman, Junguk Hur · 2022 to 2026
$3.3M
Identifying lifelong factors that impact brain health and outcomes in type 1 diabetes: The Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications StudyR01DK129320 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FELDMAN, EVA LUCILLE · 2021 to 2025
$2.3M
Elucidating the Trophic Support of Long Axons by Metabolic Signaling in OligodendrocytesR01NS111024 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BEIROWSKI, BOGDAN · 2020 to 2024
$1.9M
Energizing and Protecting Axons Through Metabolic Coupling to Schwann CellsR01NS123450 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Elisabetta Babetto, Bogdan Beirowski · 2021 to 2026
$1.9M
Sphingolipid and Fatty Acid Biology in Prediabetes and NeuropathyR00DK119366 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RUMORA, AMY E. · 2021 to 2023
$747k
Sphingolipid and Fatty Acid Biology in Prediabetes and NeuropathyK99DK119366 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUMORA, AMY E. · 2019 to 2020
$182k
LENTIVIRAL VECTOR GENE TRANSFER TO THE CNS IN MPS VIIF32NS011024 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WATSON, DEBORAH J · 2000 to 2000
$39k
Medical Research Council MR/M02394X/1Medical Research Council MR/T020113/1Medical Research Council MR/W002388/1NIDDK NIH HHS K99 DK119366NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R00 DK119366NIDDK NIH HHS R01 DK129320NIDDK NIH HHS R01 DK130913NINDS NIH HHS F32 NS011024NINDS NIH HHS R01 NS111024NINDS NIH HHS R01 NS123450Wellcome Trust 202747/Z/16/Z
6 · The paper itself

Abstract

Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D), which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy (DPN), the most common microvascular complication, is length-dependent damage to peripheral nerves. DPN pathogenesis is complex, but, at its core, it can be viewed as a state of impaired metabolism and bioenergetics failure operating against the backdrop of long peripheral nerve axons supported by glia. This unique peripheral nerve anatomy and the injury consequent to T2D underpins the distal-to-proximal symptomatology of DPN. Earlier work focused on the impact of hyperglycemia on nerve damage and bioenergetics failure, but recent evidence additionally implicates contributions from obesity and dyslipidemia. This review will cover peripheral nerve anatomy, bioenergetics, and glia-axon interactions, building the framework for understanding how hyperglycemia and dyslipidemia induce bioenergetics failure in DPN. DPN and painful DPN still lack disease-modifying therapies, and research on novel mechanism-based approaches is also covered.

Indexed as

Diabetes Mellitus, Type 2Diabetic NeuropathiesDyslipidemiasHyperglycemiaAgedHumansPeripheral Nervesbioenergeticsdiabetesdyslipidemiahyperglycemiametabolic syndromemitochondriaobesitypathophysiologyperipheral neuropathyprediabetes

Identifiers

PMID37263266
PMCPMC10525009
OpenAlexW4378840260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.